LRI Investments’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.18K Sell
9
-17
-65% -$2.18K ﹤0.01% 1175
2026
Q2
$4.93K Sell
26
-20
-43% -$2.97K ﹤0.01% 1145
2026
Q1
$4.28K Sell
46
-2,150
-98% -$190K ﹤0.01% 1134
2025
Q4
$176K Sell
2,196
-441
-17% -$36.9K 0.01% 305
2025
Q3
$257K Buy
2,637
+52
+2% +$4.19K 0.02% 256
2025
Q2
$180K Buy
2,585
+2,255
+683% +$129K 0.02% 311
2025
Q1
$16.4K Sell
330
-2,636
-89% -$167K ﹤0.01% 713
2024
Q4
$207K Buy
2,966
+2,628
+778% +$218K 0.02% 260
2024
Q3
$26.7K Sell
338
-1,822
-84% -$213K ﹤0.01% 605
2024
Q2
$307K Buy
+2,160
New +$249K 0.04% 181

Other funds holding ACLS

LRI Investments's ACLS Position: Q3 2026 in Review

LRI Investments reduced its Axcelis (ACLS) stake by 65% in Q3 2026, selling an estimated $2.18K and leaving 9 shares worth $1.18K. The position accounts for ﹤0.01% of the portfolio, ranked #1175.

LRI Investments first reported a position in ACLS in Q2 2024 and has held it in 10 quarters since. The position peaked at $307K in Q2 2024. 394 funds tracked by Wall St. Rank hold ACLS as of Q3 2026.

  • LRI Investments held 9 shares of Axcelis worth $1.18K as of Q3 2026.
  • LRI Investments sold 17 Axcelis shares in Q3 2026, an estimated $2.18K.
  • Axcelis made up ﹤0.01% of LRI Investments's portfolio in Q3 2026, its #1175 holding.
  • LRI Investments first reported a position in Axcelis in Q2 2024 and has held it in 10 quarters since.
  • LRI Investments's Axcelis position peaked at $307K in Q2 2024.
  • 394 funds tracked by Wall St. Rank held Axcelis as of Q3 2026.

Based on LRI Investments's 13F filing for Q3 2026, filed 16 Nov 2026.